Hey STAT Team - As a long time reader and biotech CEO, I wanted to pass on hopefully constructive feedback on your show in general and this specific episode. I really enjoyed hearing the inside scoop from Bryan Roberts on Kelonia and the Lilly deal. That was great. Please do more of that! In the constructive feedback category, the one thing that I would caution you on, both in this episode and others, is the trivial nature (joking, in fact) in how you handle very, very tough times for these companies and their teams. I am certain that Kelonia’s 3 “near death” experiences were EXTREMELY difficult and I would guess that many times people lost their jobs. Our fellow professionals take significant gambles with their careers and family’s well being to pursue these companies and innovations. The laughing and joking about it comes across as insensitive, as best, and ignorant, at worst (i.e. any experience working at biopharma company?). I hope this is helpful and it is coming from a constructive place. Thanks for the great work in general.
